495 related articles for article (PubMed ID: 20614439)
1. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Mulholland S; Gavranich JB; Chang AB
Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Mulholland S; Gavranich JB; Gillies MB; Chang AB
Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children.
Gavranich JB; Chang AB
Cochrane Database Syst Rev; 2005 Jul; (3):CD004875. PubMed ID: 16034954
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Gardiner SJ; Gavranich JB; Chang AB
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD004875. PubMed ID: 25566754
[TBL] [Abstract][Full Text] [Related]
5. Treatment of mycoplasma pneumonia: a systematic review.
Biondi E; McCulloh R; Alverson B; Klein A; Dixon A; Ralston S
Pediatrics; 2014 Jun; 133(6):1081-90. PubMed ID: 24864174
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin for acute lower respiratory tract infections.
Laopaiboon M; Panpanich R; Swa Mya K
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD001954. PubMed ID: 25749735
[TBL] [Abstract][Full Text] [Related]
7. Mycoplasma pneumoniae infections--does treatment help?
Spuesens EB; Meyer Sauteur PM; Vink C; van Rossum AM
J Infect; 2014 Nov; 69 Suppl 1():S42-6. PubMed ID: 25267596
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin for acute lower respiratory tract infections.
Panpanich R; Lerttrakarnnon P; Laopaiboon M
Cochrane Database Syst Rev; 2008 Jan; (1):CD001954. PubMed ID: 18253999
[TBL] [Abstract][Full Text] [Related]
9. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin for acute lower respiratory tract infections.
Panpanich R; Lerttrakarnnon P; Laopaiboon M
Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics for community-acquired pneumonia in adult outpatients.
Pakhale S; Mulpuru S; Verheij TJ; Kochen MM; Rohde GG; Bjerre LM
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD002109. PubMed ID: 25300166
[TBL] [Abstract][Full Text] [Related]
12. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.
Wang K; Gill P; Perera R; Thomson A; Mant D; Harnden A
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD009175. PubMed ID: 23076954
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
Lee H; Yun KW; Lee HJ; Choi EH
Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389
[TBL] [Abstract][Full Text] [Related]
14. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
Cao B; Qu JX; Yin YD; Eldere JV
Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
[TBL] [Abstract][Full Text] [Related]
15. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
Lung DC; Yip EK; Lam DS; Que TL
Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
[TBL] [Abstract][Full Text] [Related]
16. Mycoplasma pneumoniae and Legionella pneumophila in community-acquired lower respiratory tract infections among hospitalized children: diagnosis by real time PCR.
Maltezou HC; La-Scola B; Astra H; Constantopoulou I; Vlahou V; Kafetzis DA; Constantopoulos AG; Raoult D
Scand J Infect Dis; 2004; 36(9):639-42. PubMed ID: 15370649
[TBL] [Abstract][Full Text] [Related]
17. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.
Morozumi M; Takahashi T; Ubukata K
J Infect Chemother; 2010 Apr; 16(2):78-86. PubMed ID: 20094751
[TBL] [Abstract][Full Text] [Related]
18. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.
Principi N; Esposito S; Blasi F; Allegra L;
Clin Infect Dis; 2001 May; 32(9):1281-9. PubMed ID: 11303262
[TBL] [Abstract][Full Text] [Related]
19. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
Ouchi K
Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
[TBL] [Abstract][Full Text] [Related]
20. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
Soepandi P; Mangunnegoro H; Yunus F; Gunawan J
Respirology; 1998 Jun; 3(2):113-7. PubMed ID: 9692520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
